Philippe Morice Selected Research

Conservative Treatment

2/2022	Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma.
1/2018	Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
10/2016	Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.
11/2015	Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
6/2015	Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management.
3/2013	Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.
2/2013	Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy: should "staging" conization be systematically performed before this procedure?
10/2012	Clear cell adenocarcinoma of the female genital tract: long-term outcome and fertility aspects after brachytherapy aimed at a conservative treatment.
7/2011	Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors.
10/2009	Conservative management of low-grade endometrial stromal sarcoma followed by pregnancy and severe recurrence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Morice Research Topics

Disease

60	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2022 - 12/2003
60	Neoplasms (Cancer) 12/2021 - 07/2002
25	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2003
19	Carcinoma (Carcinomatosis) 02/2022 - 12/2003
14	Endometrial Neoplasms (Endometrial Cancer) 09/2022 - 02/2002
11	Ovarian Epithelial Carcinoma 01/2021 - 12/2002
8	Neoplasm Metastasis (Metastasis) 10/2018 - 07/2004
6	Peritoneal Diseases 11/2011 - 09/2002
5	Adenocarcinoma 01/2019 - 03/2004
3	Infertility (Sterility) 01/2019 - 03/2007
3	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 07/2013
2	Rare Diseases (Rare Disease) 01/2021 - 01/2020
2	Vaginal Neoplasms (Cancer, Vaginal) 01/2020 - 05/2018
2	Endometriosis 12/2019 - 10/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2012
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2010
2	Lymphocele 01/2018 - 01/2012
2	Melanoma (Melanoma, Malignant) 04/2013 - 07/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2007 - 09/2004
1	Uterine Diseases (Endometrial Disease) 09/2022
1	Rupture 12/2021
1	Lymphadenopathy 12/2021
1	Atrophy 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Inflammation (Inflammations) 05/2020
1	Genomic Instability 01/2020
1	Anemia 10/2018
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Leiomyoma (Uterine Fibroids) 01/2017
1	Leiomyosarcoma 02/2015
1	Teratoma (Teratoid Tumor) 02/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2014
1	Peritoneal Neoplasms 01/2014
1	Granulosa Cell Tumor 10/2013
1	Carcinogenesis 12/2012
1	Residual Neoplasm 10/2012
1	Clear Cell Adenocarcinoma 10/2012
1	Carcinoma in Situ 03/2012
1	Uterine Cervical Dysplasia 01/2011

Drug/Important Bio-Agent (IBA)

6	PlatinumIBA 01/2022 - 07/2004
5	Biomarkers (Surrogate Marker)IBA 05/2021 - 11/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2007
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2021 - 05/2008
3	Hormones (Hormone)IBA 01/2019 - 02/2010
2	lenvatinibIBA 01/2022 - 01/2021
2	pembrolizumabIBA 01/2022 - 01/2021
2	Biological ProductsIBA 01/2021 - 12/2012
2	AntigensIBA 01/2018 - 07/2002
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	cabozantinibIBA 01/2022
1	NivolumabIBA 01/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 11/2020
1	Sunitinib (Sutent)FDA Link 12/2019
1	regorafenibIBA 12/2019
1	Contraceptive Agents (Contraceptives)IBA 03/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Tamoxifen FDA LinkGeneric 01/2017
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Ifosfamide FDA LinkGeneric 02/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	Diethylstilbestrol (Stilbestrol)FDA Link 10/2012
1	Therapeutic UsesIBA 05/2012

Therapy/Procedure

44	Brachytherapy 06/2022 - 10/2002
28	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 09/2002
24	Drug Therapy (Chemotherapy) 01/2022 - 09/2002
22	Therapeutics 01/2021 - 09/2002
20	Radiotherapy 02/2021 - 10/2002
18	Conservative Treatment 02/2022 - 09/2002
16	Hysterectomy 09/2022 - 02/2002
9	Neoadjuvant Therapy 01/2022 - 02/2008
8	Cytoreduction Surgical Procedures 01/2018 - 07/2009
7	Chemoradiotherapy 05/2022 - 04/2005
7	Adjuvant Chemotherapy 01/2018 - 01/2003
6	Operative Surgical Procedures 12/2015 - 09/2002
4	Trachelectomy 10/2021 - 03/2004
4	Salpingo-oophorectomy 01/2018 - 11/2009
3	Contraindications 01/2019 - 02/2013
3	Combined Modality Therapy 01/2017 - 02/2015
2	Immunotherapy 01/2022 - 03/2006
2	Laparotomy 12/2021 - 11/2013
2	Palliative Care (Palliative Therapy) 02/2021 - 01/2021
2	Hormonal Contraception 01/2019 - 03/2018
2	Contraception (Birth Control) 01/2019 - 03/2018
2	Morcellation 01/2017 - 06/2014
2	Cystectomy 03/2012 - 05/2006
2	Curettage 01/2005 - 12/2002
1	Re-Irradiation 03/2021
1	Ileostomy 01/2018
1	Perioperative Care 11/2016
1	Hyperthermic Intraperitoneal Chemotherapy 10/2013
1	Precision Medicine 12/2012
1	Epidural Analgesia 04/2012
1	Analgesia 04/2012